Differences in pharmacology and their translation into differences in clinical efficacy – a comparison of the renin angiotensin blocking agents irbesartan and losartan

  • Peter Bramlage, Christoph Schindler
  • Expert Opinion on Pharmacotherapy, December 2009, Informa Healthcare
  • DOI: 10.1517/14656560903512962

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Peter Bramlage